Home / About Novasep / Media & Events / Press releases

Press releases

Novasep launches the Sius(TM) single-use TFF skid, completing the first 100 per cent single-use TFF solution for pre-clinical to clinical cGMP biomanufacturing

14 Feb 2013

Sius(TM) TFF skid to be showcased at the Disposable Solutions for Biomanufacturing tradeshow in Brussels on February 19-20, 2013.


Novasep invests EUR 30 million to build world’s largest chromatography plant for the pharmaceutical industry

10 Oct 2012

New plant on its Mourenx, France site to produce a large volume commercial API.


Changes to Novasep governance Roger-Marc Nicoud becomes Non-Executive Chairman of the Board Patrick Glaser, Head of Novasep Synthesis, is appointed President and CEO - (10/2/2012)

02 Oct 2012

Pompey, France, 2nd October 2012 - Novasep, a leading provider of purification-based manufacturing solutions for life science molecules, today announces the appointment of Roger-Marc Nicoud, founder and CEO, as Non-Executive Chairman of the Board, effective on October 1st, 2012.


Novasep invests 3 million euros to boost its HPAPI manufacturing capabilities - (7/19/2012)

19 Jul 2012

Pompey, France, July 19, 2012 - Novasep, a leading supplier of manufacturing solutions to the life sciences industries, announces today a three million euro investment to expand its Highly Potent API (HPAPI) manufacturing capabilities at its Le Mans (France) facility. The expansion has been designed to allow Novasep to serve the increased demand for manufacturing of novel anti-cancer therapies.


Novasep strengthens its management team with the appointment of Jean-Claude Romain as Corporate Quality Director and Alain Lamproye as Director of Novasep Bioproduction sites in Belgium - (4/23/2012)

23 Apr 2012

Pompey, France, April 23, 2011 – Novasep, a leading supplier of purification and production solutions for the life sciences industry, announces two new managerial appointments. Jean-Claude Romain becomes the group’s Corporate Quality Director and a member of Novasep’s executive committee, while Alain Lamproye joins Novasep Process, the company’s biomolecules division, as Director of Novasep Belgium and becomes a member of Novasep Process’s management committee.


Novasep’s outstanding results in scale-up and biomanufacturing of Apo-A1 acknowledged by Cerenis at BioProcess International Conference - (4/16/2012)

16 Apr 2012

Cerenis Therapeutics to present manufacturing data for this biopharmaceutical against atherosclerotic cardiovascular disease at BioProcess International (BPI) Conference in Prague (Czech Republic), April 18, 2012.


Novasep opens new 2,000 m² expanded Shanghai facilities to meet increasing East Asia demand - (3/27/2012)

27 Mar 2012

New site increases Novasep’s process development and engineering capabilities to supply turnkey purification processes in East Asia.


Novasep announces major recapitalization to boost its growth - (3/21/2012)

21 Mar 2012

A strongly improved balance sheet, new shareholders and an entrepreneurial management to support the group’s development going forward.


Novasep launches AbSolute® High Cap - (10/31/2011)

31 Oct 2011

New protein A media boosts productivity in monoclonal and polyclonal antibody capture, lowers costs.




You can stay on this page and select more documents or you can directly download the brochure(s) you selected
Give us your feedback!